0
Back To Top Jump Location
Sign In  | Cart
Left Shadow
Right Shadow
Correspondence |

Reply FREE

Pooja Khatri, MD; Scott E. Kasner, MD; Daniel Kolansky, MD
[+] Author Information

University of Cincinnati, Department of Neurology, 260 Stetson Street, Suite 2308, P.O. Box 670525, Cincinnati, Ohio 45267

American College of Cardiology Foundation

J Am Coll Cardiol. 2008;52(4):317-318. doi:10.1016/j.jacc.2008.04.022
Published online

We thank Drs. De Marco, Routledge, and Lefèvre for their interest in our work (1). They raise the important question of whether to take the time to do an imaging study before administering cerebral reperfusion therapy in the setting of stroke after cardiac catheterization. They have proposed immediate acute stroke treatment, transitioning directly from cardiovascular to cerebral angiography for intra-arterial therapy, for strokes after cardiac catheterization on the table. However, the limited reports on this topic are likely subject to a publication bias toward favorable clinical outcomes.

Even if an embolism is identified on an immediate cerebral angiogram, the possibility of an acute hemorrhagic infarction remains a concern, particularly in the setting of antithrombotics and anticoagulants. Studies discriminating stroke subtypes have reported hemorrhagic strokes in 24% (2) and 46.5% (3) of cases.

While we agree that, in most circumstances, the added delay of magnetic resonance imaging (MRI) is not warranted, a computed tomography (CT) scan can and should be accomplished in no longer than 15 min. Typically, this time could be used for concurrent stroke team evaluation and participation.

Among our 12 recombinant tissue plasminogen activator cases, 1 was treated without acute imaging, 1 received MRI, and 10 received CT scans. Among the 54 cases not treated acutely, 6 received MRI and 48 received CT scans.

The 3 asymptomatic intracranial hemorrhages reported in our study occurred with intra-arterial thrombolysis initiation at 54, 265, and 305 min. While longer times to treatment initiation may be associated with higher rates of symptomatic hemorrhage, the relationship of time and asymptomatic hemorrhage has not been established (4). In fact, mild radiological subtypes of intracranial hemorrhage may actually mark early reperfusion and good clinical outcome, compared with cases without hemorrhage (5). Nevertheless, we agree that time to treatment is a critical determinant of good clinical outcome after stroke.

In summary, we favor an immediate CT scan of the head before stroke reperfusion therapy in the setting of stroke after cardiac catheterization. It should result in minimal loss of time if concurrent with stroke team activation and evaluation and will provide important diagnostic and therapeutic information.

References

Khatri  P., Taylor  R.A., Palumbo  V.;Treatment of Acute Stroke After Cardiac Catheterization (TASCC) Study Group The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol. 51 2008:906-911.
CrossRef | PubMed
Dukkipati  S., O'Neill  W.W., Harjai  K.J.; Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol. 43 2004:1161-1167.
CrossRef | PubMed
Fuchs  S., Stabile  E., Kinnaird  T.D.; Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation. 106 2002:86-91.
CrossRef | PubMed
Khatri  P., Wechsler  L.R., Broderick  J.P.; ICH associated with revascularization therapies. Stroke. 38 2007:431-440.
CrossRef | PubMed
Molina  C.A., Alvarez-Sabin  J., Montaner  J.; Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 33 2002:1551-1556.
CrossRef | PubMed

Figures

Tables

Interactive Graphics

Video

References

Khatri  P., Taylor  R.A., Palumbo  V.;Treatment of Acute Stroke After Cardiac Catheterization (TASCC) Study Group The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol. 51 2008:906-911.
CrossRef | PubMed
Dukkipati  S., O'Neill  W.W., Harjai  K.J.; Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol. 43 2004:1161-1167.
CrossRef | PubMed
Fuchs  S., Stabile  E., Kinnaird  T.D.; Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation. 106 2002:86-91.
CrossRef | PubMed
Khatri  P., Wechsler  L.R., Broderick  J.P.; ICH associated with revascularization therapies. Stroke. 38 2007:431-440.
CrossRef | PubMed
Molina  C.A., Alvarez-Sabin  J., Montaner  J.; Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 33 2002:1551-1556.
CrossRef | PubMed

Correspondence

Latest JACC CME

Continuing Medical Education through JACC is a convenient way to fulfill your CME requirements while learning important information about the latest advances in cardiovascular medicine.

April 2013- JACC CME Activity
Repeat Revascularization and Outcome

March 2013- JACC CME Activity
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Feb 2013- JACC CME Activity
Results from the BARI 2D Trial

Jan 2013- JACC CME Activity
Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope

Dec 2012- JACC CME Activity
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Nov 2012- JACC CME Activity
A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials

Oct 2012- JACC CME Activity
Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

Sept 2012- JACC CME Activity
Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

Aug 2012- JACC CME Activity
Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

July 2012- JACC CME Activity
Relationship of Beta-Blocker Dose With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

For previous CME quizzes, please follow this link to CardioSource Lifelong Learning and MOC.

 

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Topics